0001628280-23-008356.txt : 20230316
0001628280-23-008356.hdr.sgml : 20230316
20230316174211
ACCESSION NUMBER: 0001628280-23-008356
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230315
FILED AS OF DATE: 20230316
DATE AS OF CHANGE: 20230316
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Levine James E.
CENTRAL INDEX KEY: 0001463151
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35558
FILM NUMBER: 23740002
MAIL ADDRESS:
STREET 1: 55 CAMBRIDGE PARKWAY
STREET 2: 8TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cardiff Oncology, Inc.
CENTRAL INDEX KEY: 0001213037
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 272004382
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11055 FLINTKOTE AVENUE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-952-7570
MAIL ADDRESS:
STREET 1: 11055 FLINTKOTE AVENUE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: Trovagene, Inc.
DATE OF NAME CHANGE: 20130304
FORMER COMPANY:
FORMER CONFORMED NAME: TrovaGene Inc.
DATE OF NAME CHANGE: 20110830
FORMER COMPANY:
FORMER CONFORMED NAME: XENOMICS INC
DATE OF NAME CHANGE: 20040719
4
1
wf-form4_167900291678685.xml
FORM 4
X0306
4
2023-03-15
0
0001213037
Cardiff Oncology, Inc.
CRDF
0001463151
Levine James E.
C/O CARDIFF ONCOLOGY, INC.
11055 FLINTKOTE AVE
SAN DIEGO
CA
92121
0
1
0
0
Chief Financial Officer
Stock Options
1.72
2023-03-15
4
A
0
197472
0
A
2033-03-15
Common Stock
197472.0
757488
D
25% of the shares subject to the option will vest on March 15, 2024 and the remaining shares vest in 36 equal monthly installments thereafter, subject to the continued service of the reporting person.
/s/ James Levine
2023-03-16